North America Interventional Oncology Market Overview:
The North America Interventional Oncology Market to reach USD 1,150.5 million by 2025 from USD 705.0 million in 2018, growing at a CAGR of 7.37% during the forecast period 2025.Interventional oncology is a branch of medical science that deals with minimally invasive medical procedures performed by interventional radiologists for the diagnosis, treatment and palliation of different types of cancer.
Browse details of 140 number of pages research report developed on North America Interventional Oncology Market Research Report @ https://www.researchcosmos.com/reports/north-america-interventional-oncology-market/815710683
Drivers, Challenges and Opportunities of North America Interventional Oncology Market:
The growing demand for minimally invasive therapies has been the propelling factor for the North American interventional oncology market. The ability of these techniques to treat cancer cells better than alternative treatments, such as radiotherapy, surgery and routine chemotherapy, has allowed this technique to gain popularity through the region. In addition, health professionals and patients are progressively opting for minimally invasive procedures in the area of interventional oncology because of the advantages such as shorter hospital stay, minimal risk of infection, less complications, less pain and faster recovery time compared to conventional surgeries. These benefits of using minimally invasive procedures will further stimulate the growth of the interventional oncology market in North America.
Interventional oncology is used to treat primary or metastatic cancer, such as liver cancer, kidney cancer, lung cancer, prostate cancer, breast cancer and pancreatic cancer, which is also another supporting factor for the local market. Due to its minimally invasive nature, the required recovery time is minimal along with the hospital stay. Some of the popular procedures in the business are pain palliation, intra-arterial therapies, ablative therapies and neoadjuvant procedures.
Ask Free Sample of the Report @ https://www.researchcosmos.com/request/north-america-interventional-oncology-market/815710683
Geographic Segmentation:
North America is expected to be an important part of the interventional oncology market due to its large population affected by chronic cancer, such as hepatocellular carcinoma, lung cancer, kidney cancer and metastatic colorectal cancer. In addition, the significant adoption of minimally invasive surgeries for effective cancer management, a well-established health infrastructure and rapid adoption of state-of-the-art products is boosting the market, which will result in more acceptance among the population over the forecast period.
Some of the prominent players in the North America Interventional Oncology Market are: Boston Scientific Corporation, Medtronic plc, Terumo Corporation, BTG plc, AngioDynamics, Inc., Ethicon, Inc. (Johnson & Johnson), Merit Medical Systems, Inc. and Sirtex Medical Limited, Siemens Healthineers, Eckert & Ziegler BEBIG, Varian Medical Systems, Inc. and HealthTronics, Inc etc.
For any queries, inquire more @ https://www.researchcosmos.com/inquire/north-america-interventional-oncology-market/815710683
About Us:
Research Cosmos is a provider of standard and customized Industry research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending Industry reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Media Contact
Company Name: Research Cosmos
Contact Person: Kevin Stewart
Email: Send Email
Phone: 1-888-709-8757
Address:4390 U.S 1, Suite 211
City: Princeton
State: New Jersey
Country: United States
Website: https://www.researchcosmos.com/reports/north-america-ultrasound-probe-disinfection-market/971882895